| Dataset | H3K9me3 |
| Phenotype | NoPhenotypeAvailable |
| Upregulated in class | na_pos |
| GeneSet | DESCARTES_FETAL_EYE_GANGLION_CELLS |
| Enrichment Score (ES) | 0.56349444 |
| Normalized Enrichment Score (NES) | 1.3249111 |
| Nominal p-value | 0.017 |
| FDR q-value | 0.7216489 |
| FWER p-Value | 1.0 |

| SYMBOL | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|
| 1 | IRX4 | 371 | 1.884 | 0.0577 | Yes |
| 2 | ISLR2 | 1192 | 1.286 | 0.0725 | Yes |
| 3 | POU4F2 | 1229 | 1.270 | 0.1207 | Yes |
| 4 | GPR139 | 1593 | 1.158 | 0.1503 | Yes |
| 5 | SLC17A6 | 1870 | 1.081 | 0.1807 | Yes |
| 6 | POU4F1 | 1886 | 1.076 | 0.2222 | Yes |
| 7 | TFAP2D | 2126 | 1.021 | 0.2518 | Yes |
| 8 | NRN1 | 2437 | 0.964 | 0.2761 | Yes |
| 9 | SYT5 | 2805 | 0.905 | 0.2956 | Yes |
| 10 | CLEC2L | 3040 | 0.869 | 0.3195 | Yes |
| 11 | PRPH | 3154 | 0.853 | 0.3480 | Yes |
| 12 | GPR149 | 3175 | 0.851 | 0.3805 | Yes |
| 13 | EOMES | 3206 | 0.847 | 0.4124 | Yes |
| 14 | SYNGR3 | 3251 | 0.842 | 0.4434 | Yes |
| 15 | RAB37 | 3280 | 0.838 | 0.4750 | Yes |
| 16 | INA | 3740 | 0.792 | 0.4861 | Yes |
| 17 | GAP43 | 4893 | 0.686 | 0.4630 | Yes |
| 18 | TMEM163 | 4917 | 0.685 | 0.4888 | Yes |
| 19 | LRRC73 | 5633 | 0.633 | 0.4826 | Yes |
| 20 | AKAIN1 | 5634 | 0.632 | 0.5073 | Yes |
| 21 | TUBBP5 | 5720 | 0.626 | 0.5282 | Yes |
| 22 | P2RX3 | 6263 | 0.592 | 0.5278 | Yes |
| 23 | LGI3 | 6369 | 0.587 | 0.5463 | Yes |
| 24 | CHRNB3 | 6496 | 0.579 | 0.5635 | Yes |
| 25 | LINC01606 | 7529 | 0.526 | 0.5393 | No |
| 26 | TMEM74 | 8393 | 0.485 | 0.5208 | No |
| 27 | CHRNA6 | 8642 | 0.472 | 0.5285 | No |
| 28 | IL1RL2 | 9522 | 0.436 | 0.5074 | No |
| 29 | KIF5A | 10682 | 0.391 | 0.4724 | No |
| 30 | IL12A | 11636 | 0.354 | 0.4449 | No |
| 31 | B4GALNT1 | 12887 | 0.305 | 0.4026 | No |
| 32 | OPN4 | 14834 | 0.228 | 0.3270 | No |
| 33 | FNDC9 | 14872 | 0.226 | 0.3343 | No |
| 34 | C1QTNF1-AS1 | 15546 | 0.200 | 0.3129 | No |
| 35 | SYT2 | 15642 | 0.196 | 0.3165 | No |
| 36 | CEND1 | 16656 | 0.149 | 0.2783 | No |
